Access Bio Signs $26.1 Billion Supply Contract for COVID-19 Test Kits with U.S. Medical Company

[Asia Economy Reporter Park Jun-yi] Access Bio announced on the 8th that it has signed a supply contract worth 24 million USD (approximately 26.0832 billion KRW) for COVID-19 antigen test kits with the US medical device distributor Intrivo Diagnostics.

The contract amount is 60.58% of the consolidated sales based on 2019. The contract ends on March 6.